Pancreatic surgeon Dr. Beth Schrope starts her mornings without an alarm, enters the OR right foot first, and never overlooks the small things that can make a patient’s day a little easier.
As the FDA approved a new targeted therapy for metastatic pancreatic cancer, an early-stage Columbia trial offers another encouraging signal that one of cancer’s most stubborn diseases may be entering a new era of treatment.
An interview with John A. Chabot, MD, Chief of the Division of GI/Endocrine Surgery and Executive Director of the Pancreas Center, about the latest in pancreatic care.
We are thrilled to announce the winners of the 2024 Ruth Leff Seigel Awards for pancreatic cancer research, Sita Kugel, PhD and Kazuki N. Sugahara, MD, PhD.
We are honored to announce a call for nominations for the 12th annual Ruth Leff Siegel Award for Excellence in Pancreatic Cancer Research. The Pancreas Center at Columbia University and The Herbert Irving Comprehensive Cancer Center have been entrusted by the Siegel family to identify the investigator who has made the most impactful contribution to the understanding and/or treatment of pancreatic cancer over the past year.
